Skip to content
Screener

BioLife Solutions BLFS Other Non-Current Assets

Other Non-Current Assets at other companies

Danaher logo
DanaherDHR
$4.39B+18.9%
Azenta logo
AzentaAZTA
$51.45M
TEC
Bio-TechneTECH
$264.37M-1.7%
Revvity logo
RevvityRVTY
$309.11M-3.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$102.8M-0.9%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$51.56M-82.6%

Other financials

Income statement

See full
Revenue$28.5M+21.5%
Gross profit$18.3M+20.0%
Operating income$1.7M+111%
Net income$45.1M+385%
EPS (diluted)$0.91+376%

Balance sheet

See full
Cash & equivalents$24.0M-24.8%
Total debt$15.7M-33.9%
Total equity$420.0M+21.0%
Total assets$447.5M+15.6%

Cash flow

See full
Operating cash flow$6.3M-13.8%
CapEx$1.0M-40.2%
Free cash flow$5.3M-5.7%

Valuation

See full
Market cap$1.7B+56.2%
Enterprise value$1.69B+56.7%
P/E54.6×
P/S16.5×+3.3×

Profitability

See full
Gross margin67.2%
Operating margin1.6%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio9.7×+5.3×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:22 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054355
(In thousands, except per share and share data)June 30, 2026December 31, 2025
Total current assets135,198136,561
Property and equipment, net15,23514,713
Operating lease right-of-use assets, net8,6447,466
Other assets3,2893,050
Available-for-sale securities, long-term30,65431,250
Intangible assets, net3,6544,257
Deferred tax assets, net42,233
Goodwill208,587208,587

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is BioLife Solutions's other non-current assets?
BioLife Solutions (BLFS) reported other non-current assets of $3.29M in Q2 2026.
How has BioLife Solutions's other non-current assets changed year-over-year?
BioLife Solutions's other non-current assets increased by 770.1% year-over-year, from $378K to $3.29M.
What is the long-term trend for BioLife Solutions's other non-current assets?
Over 5 years (2020 to 2025), BioLife Solutions's other non-current assets has grown at a 67.7% compound annual growth rate (CAGR), from $230K to $3.05M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about BioLife Solutions's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude